Name | Number of supported studies | Average coverage | |
---|---|---|---|
type II pneumocyte | 11 studies | 70% ± 27% | |
type I pneumocyte | 9 studies | 41% ± 18% | |
glutamatergic neuron | 3 studies | 22% ± 3% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 20% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 268.69 | 653 / 653 | 89% | 5.36 | 539 / 605 |
lung | 100% | 12110.44 | 577 / 578 | 79% | 80.56 | 908 / 1155 |
prostate | 96% | 79.84 | 234 / 245 | 77% | 1.48 | 385 / 502 |
pancreas | 100% | 133.06 | 328 / 328 | 41% | 0.87 | 73 / 178 |
brain | 94% | 129.34 | 2482 / 2642 | 46% | 0.96 | 327 / 705 |
kidney | 93% | 71.44 | 83 / 89 | 33% | 0.58 | 297 / 901 |
uterus | 69% | 33.78 | 117 / 170 | 42% | 2.19 | 195 / 459 |
esophagus | 88% | 63.75 | 1267 / 1445 | 14% | 0.51 | 25 / 183 |
ovary | 42% | 40.54 | 76 / 180 | 57% | 2.42 | 247 / 430 |
breast | 69% | 36.48 | 315 / 459 | 27% | 0.71 | 302 / 1118 |
blood vessel | 89% | 75.66 | 1186 / 1335 | 0% | 0 | 0 / 0 |
stomach | 84% | 47.42 | 300 / 359 | 2% | 0.06 | 7 / 286 |
liver | 73% | 34.07 | 164 / 226 | 10% | 0.22 | 41 / 406 |
adrenal gland | 15% | 8.41 | 39 / 258 | 63% | 2.01 | 146 / 230 |
skin | 73% | 166.53 | 1326 / 1809 | 5% | 0.49 | 24 / 472 |
heart | 69% | 36.82 | 590 / 861 | 0% | 0 | 0 / 0 |
intestine | 60% | 34.91 | 577 / 966 | 3% | 0.30 | 18 / 527 |
bladder | 38% | 16.24 | 8 / 21 | 16% | 6.78 | 81 / 504 |
adipose | 53% | 28.64 | 642 / 1204 | 0% | 0 | 0 / 0 |
spleen | 53% | 23.11 | 127 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 27% | 0.68 | 12 / 45 |
peripheral blood | 25% | 13.34 | 232 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 21% | 0.29 | 17 / 80 |
muscle | 5% | 2.20 | 42 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0050766 | Biological process | positive regulation of phagocytosis |
GO_0048286 | Biological process | lung alveolus development |
GO_0032703 | Biological process | negative regulation of interleukin-2 production |
GO_0006898 | Biological process | receptor-mediated endocytosis |
GO_0045087 | Biological process | innate immune response |
GO_0072593 | Biological process | reactive oxygen species metabolic process |
GO_0042130 | Biological process | negative regulation of T cell proliferation |
GO_0043129 | Biological process | surfactant homeostasis |
GO_0001817 | Biological process | regulation of cytokine production |
GO_0042742 | Biological process | defense response to bacterium |
GO_0048246 | Biological process | macrophage chemotaxis |
GO_0007585 | Biological process | respiratory gaseous exchange by respiratory system |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0030139 | Cellular component | endocytic vesicle |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005764 | Cellular component | lysosome |
GO_0005581 | Cellular component | collagen trimer |
GO_0005771 | Cellular component | multivesicular body |
GO_0045334 | Cellular component | clathrin-coated endocytic vesicle |
GO_0030246 | Molecular function | carbohydrate binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | SFTPD |
Protein name | Pulmonary surfactant-associated protein D Surfactant protein D Pulmonary surfactant-associated protein D (PSP-D) (SP-D) (Collectin-7) (Lung surfactant protein D) |
Synonyms | COLEC7 PSPD SFTP4 |
Description | FUNCTION: Contributes to the lung's defense against inhaled microorganisms, organic antigens and toxins. Interacts with compounds such as bacterial lipopolysaccharides, oligosaccharides and fatty acids and modulates leukocyte action in immune response. May participate in the extracellular reorganization or turnover of pulmonary surfactant. Binds strongly maltose residues and to a lesser extent other alpha-glucosyl moieties. . |
Accessions | ENST00000372292.8 Q5T0M2 ENST00000444384.3 P35247 G5CCM8 |